As quoted by ASCO
“Cancer patients represent a vulnerable population, as they often need complex and intensive health care services when diagnosed and if they have a cancer recurrence,” the letter stated. “For many people, therapies are targeted according to tumor type and genetics, so drug coverage under the essential health benefits must consider this movement toward targeted cancer treatment.”
Read more:
http://ascoaction.asco.org/Home/tabid/41/articleType/ArticleView/articleId/228/categoryId/47/Cancer-Leadership-Council-Urges-HHS-to-Set-Standard-Health-Benefits-Under-ACA.aspx